US Supreme Court rejects Teva challenge to USD 235 million GSK award in patent dispute Ruchika Sharma16 May 2023 9:14 AM GMTGSK responded in a court brief that the case "presents no threat to generic companies who operate properly under the law."
Canada court dismissed Zantac litigation: GSK Ruchika Sharma13 May 2023 7:00 AM GMTBengaluru: The British Columbia Supreme Court dismissed a proposed class action in Canada against heartburn drug Zantac over increased cancer risk,...
GSK raises USD 1 billion selling shares in Haleon Consumer Spinoff: Bloomberg Ruchika Sharma12 May 2023 7:00 AM GMTSince the spinoff, GSK has said that it intended to treat its stake in Haleon like a financial investment.
Pfizer plan to sell its Haleon stake is not surprise: Consumer health company Finance chief Ruchika Sharma4 May 2023 8:00 AM GMTHestler said Pfizer has long been clear about its intention to sell off the stake, suggesting that the reason the potential of the selloff has gained...
World's first RSV vaccine: GSK wins USFDA nod for Arexvy in older adults Ruchika Sharma4 May 2023 6:18 AM GMTRespiratory syncytial virus is a common contagious virus affecting the lungs and breathing passages.
GSK gets positive EMA panel opinion for Respiratory syncytial virus older adult vaccine Ruchika Sharma29 April 2023 9:00 AM GMTGSK's RSV older adult vaccine candidate contains a recombinant subunit RSV prefusion F glycoprotein antigen (RSVPreF3) combined with the Company's...
GSK beats expectations for Q1 revenue, profit Ruchika Sharma27 April 2023 9:00 AM GMTLondon: GSK on Wednesday beat expectations for its first-quarter revenue and profit, helped by sales of its blockbuster shingles vaccine Shingrix.The...
GSK Shingles vaccine Shingrix now in India Ruchika Sharma26 April 2023 9:57 AM GMTShingrix is a non-live vaccine it can be offered to those, above the age of 50 years, who are immunocompromised and/or immunosuppressed and who are...
GSK plans to acquire Bellus Health for USD 2 billion Ruchika Sharma18 April 2023 11:35 AM GMTAt the heart of the deal - announced by both companies on Tuesday - is the experimental drug, camlipixant, which is in late-stage development for...
GSK oral antibiotic drug to treat uncomplicated urinary tract infections meets main goals in late stage trials Ruchika Sharma17 April 2023 9:09 AM GMTThe drug, if approved, could become the first new type of antibiotic, which is critically important for countering drug-resistant infections, to treat...
Pay AstraZeneca royalties on total sales of ovarian cancer drug Zejula: UK Court orders GSK's Tesaro Ruchika Sharma6 April 2023 4:30 AM GMTUK: A UK court on Wednesday ordered GSK's Tesaro to pay rival AstraZeneca royalties on total sales of ovarian cancer drug Zejula, in a win for the...
British drugmaker GSK sees USD 500 million peak sales for yeast infection pill licensed from Scynexis Ruchika Sharma2 April 2023 10:30 AM GMTLondon: British drugmaker GSK sees peak sales of more than $500 million for a drug to treat yeast infections that it licensed from US biotech company...
